
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
UCB | Brussels | EUR | Real-time | |
UCBb | BATS Europe | EUR | Delayed | |
UCBJY | OTC Markets | USD | Delayed | |
0NZT | London | EUR | Real-time | |
UCB | TradeGate | EUR | Delayed | |
UCB | Frankfurt | EUR | Delayed |
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.
Name | Age | Since | Title |
---|---|---|---|
Guy Keutgen | - | 1990 | Honorary Director |
Mark Eyskens | - | 2005 | Honorary Chairman |
Norman J. Ornstein | 74 | 2008 | Honorary Director |
Karel Boone | 79 | 2000 | Honorary Chairman |
Arnoud de Pret Roose de Calesberg | 78 | 2005 | Honorary Director |
Jonathan M. Peacock | 64 | 2021 | Independent Director |
Charles-Antoine Emmanuel T. Janssen | 51 | 2012 | Director |
Gaëtan van de Werve | - | 2006 | Honorary Director |
Albrecht De Graeve | 67 | 2010 | Independent Director |
Cyril Janssen | 51 | 2015 | Director |
Dame Kay Davies | 71 | 2014 | Independent Director |
Stefan Oschmann | 65 | 2021 | Independent Chairman of the Board |
Jean-Louis Vanherweghem | - | - | Honorary Director |
Jean-Pierre Kinet | 69 | 2008 | Honorary Director |
Daniel Janssen | 86 | - | Honorary Deputy Chairman |
Jonkheer Cédric van Rijckevorsel | 52 | 2014 | Director |
Alice Dautry | 72 | 2015 | Honorary Director |
Prince Lorenz | - | 2001 | Honorary Director |
Peter J. Fellner | 79 | 2005 | Honorary Director |
Alan John Blinken | - | - | Honorary Director |
Thomas Fulton Wilson McKillop | 79 | 2009 | Honorary Director |
Fiona du Monceau | 44 | 2021 | Vice-Chair of the Board |
Frederic Roch Doliveux | 66 | 2005 | Honorary Director |
Ulf Arne Wiinberg | 64 | 2016 | Independent Director |
Viviane Monges | 59 | 2017 | Independent Director |
Pierre L. Gurdjian | 61 | 2016 | Independent Director |
Gerhard N. Mayr | 76 | 2005 | Honorary Chairman |
Diégo du Monceau de Bergendal | 72 | 1984 | Honorary Chairman |
Georges Jacobs de Hagen | 82 | 2005 | Honorary Chairman |
Jean-Christophe Tellier | 63 | 2014 | CEO & Executive Director |
Jean van Rijckevorsel | - | 1992 | Honorary Director |
Jan Berger | 65 | 2019 | Independent Director |
Susan Gasser | 67 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review